Member Info for stocksaint

Bighammer, There are specialist healthcare funds that could have invested something in GDR within the past couple of years, but they don't. They choose not to. GDR used to have that kind of back a few years back. If they still don't come back within next few months would be sceptical about prospects for either product (it might just be down to timelines and uncertainty). GDR may engineer some kind of placing without a named investor I suppose - a kind of fast in and out by bucket shops as they did in their last traditional placing some time ago. But that's not quite the same as having a couple of long term iis on board.

Yes, and also just read this bit in a Times article from mid Feb:

Lisa Anson, the chief executive of Redx, said that most of the large specialist biotechnology investors were based in the United States, “so inevitably you start to look more and more towards the US investor base. And in order to access those pools of capital you do need to be ultimately US-listed. So we will look at that as a board. We have managed to attract US investment, notwithstanding the fact that we are listed on Aim.”

Business briefing Morning and midday updates on financial and economic news from our award-winning business team. Sign up with one click

Asked whether Redx would look to switch its listing from Britain to America or would have a dual listing, she said: “The board will look at quite a number of options.”

As you said yesterday moniman, perhaps the reason to delist is just to get the valuation up private - before a US listing within 12 months from...?!

Interesting how C4 seems to have held up better with similar type of announcement. Guess the PI shareholder base here was just weaker at the onset...

I didn't expect the SP to fall again today! But from the share trades looks like someone is taking advantage of it.

Good point Jimi. Might be difference between short and long term though. I noticed NHS are now ADVERTISING for people to get hepatitis tests. So it seems like they have expanded lab capacity for that quite a lot. Just saying, I think this could go the same way in the end.

Slacker, I think my post not clear. Was actually talking about prospects for the stroke test. If you read the guidance it says to recommend "when lab testing not available"!! (That's why I think it a bit different to AIHL)

Jimi,

I think different to AIHL situation as guidance seems to be saying that it's just to be used when lab testing not available and also for certain stroke patients. But it seems you're right, if trusts want to use, they should be able to get funding for it from the central NHS budget is my take. How many of them will take it up straight away? Who knows. Makes me think a bit like what happened with their hepatitis solution could happen, where in the end the NHS basically goes all in on lab testing instead.

Interesting this time people have negative sentiment after presentation, when many on here seemed to be quite up beat after the last one. I not watched latest yet. The obvious thing is they not yet saying how they going to keep the lights on beyond next month, right!

I put in transfer application for my SIPP to AJ Bell as can't see my current broker facilitating order matching with Jenkins. I asked for an "investments" transfer. The transfer will take 4-6 weeks by the looks of it, but REDX will be private before that anyway as things appear. Not sure if that could cause an issues for the transfer?

I had a look at Jenkins website last night, but couldn't tell if it's an auction process every few months or more regular ad. hoc buying and selling?

Brokers now connected on an automated basis to the JP Jenkins platform include IG, Jarvis, AJ Bell, Charles Stanley (LSE:CAY), James Sharpe, Hargreaves Lansdown, Investec, Kyte, Rathbone, Ramsey Crookall, Interactive Investor, ITI, Intrinsic, Albert E Sharpe, Killik, Raymond James, FIS Global, Winterflood Securities and Shore Capital.

https://www.proactiveinvestors.co.uk/companies/news/1042401/brokers-flock-to-jp-jenkins-private-liquidy-venue-1042401.html

It does kind of makes sense to me. I noticed some days on here the price would go down by about 7% just because someone flogged £900 worth of shares as liquidity was so low

On your point earlier Moniman, also just noticed the bit below is highlighted in bold. But not sure what real significance/punchline this could have on us?? The US still has regs. Why delist here if you're planning to list in the US fairly soon. Why not just wait till you're ready to list there? Perhaps they just want to keep options open...

However, the composition of the Board is expected to change shortly following the Cancellation and Re-registration and it is expected that such changes will mean that the Company would no longer have its place of central management and control in the United Kingdom for the purposes of the Takeover Code from that time. Therefore, if the Cancellation and Re-registration are approved by Shareholders at the General Meeting and become effective, the Takeover Code will cease to apply to the Company with effect from such changes to the composition of the Board being made.

To me they can argue final decision has still not been taken cause technically it's still pending a shareholder vote....

My guess is worse case scenario with them is you won't be able to trade it until you move it. But it will still show up on the platform as a non tradeable investment.

Big problem with AIM these days is lack of liquidity for loads of shares....

I think the people who've been watching this/invested in for a while know this rally isn't going to age well. The recommendation just means they'll be able to get it started in Manchester. It will be years before the stroke product brings in big revenue. The big question mark for me is if they'll even be a proper funding raising this month, if they can actually get IIs on board again. This will likely trade in the 2s before the month is out, or even worse am afraid.

It wasn't this stock though was it longfell. I confident there's value here that will be realised in the end. It may take some time though...

Moniman, Mine is mainstream. It's held in a SIPP. I just spoke to someone and they seemed very sure it will still be held/can still be held and appear in the SIPP. But as it's important I asked if they can send an email to clarify, which they've agreed to do. So I think they going to double check for me. I'll let you know what they say. Guess it might vary from provider to provider though.

Moniman,

I read this morning from various sources that private shares like this can be held in a SIPP. However, it depends on the provider. The matching order facility may mean that even the mainstream providers allow them to be hold. Worse case scenario I see is I'll need to move to another SIPP provider.

Does anyone know how much Polar still holds? FT data appears to show they still the second largest shareholder, though guessing might be out of date. How much in total is held by proper IIs like Polar by the way? (not in platforms like IG etc)